Scottsdale, AZ - Oral anticoagulants are superior to antiplatelet therapy for primary stroke prevention in patients with nonvalvular atrial fibrillation (AF), according to a new report published in ...

Combined oral anticoagulant and antiplatelet therapy is associated with a worse prognosis than anticoagulation alone in newly diagnosed atrial fibrillation patients without a clear indication for ...

Munich, Germany - 28 Aug 2018: Combined oral anticoagulant and antiplatelet therapy is associated with a worse prognosis than anticoagulation alone in newly diagnosed atrial fibrillation patients ...

Clinical benefits of direct oral anticoagulants in addition to antiplatelet therapy as a secondary prevention after ACS may be dependent on type of ACS, according to results published in JAMA ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Antiplatelet and anticoagulant medication ...

Patients with atrial fibrillation who took oral anticoagulants alone after undergoing transcatheter aortic valve replacement (TAVR) had a lower rate of bleeding complications without an increased risk ...

Patients with newly diagnosed atrial fibrillation who take not only an oral anticoagulant (OAC) but also an antiplatelet face increased risks of stroke and bleeding at 1 year, according to an analysis ...

Ischemic adverse events, such as loss of vision and, less frequently, strokes, are the hallmarks of giant cell arteritis (GCA). Antiplatelet and anticoagulant therapy is thought to reduce the risk of ...

Patients with atrial fibrillation (AF) taking oral anticoagulants for stroke prevention face a higher risk of bleeding when taking concomitant antiplatelet agents. WASHINGTON, DC—Findings from the ...

Despite favourable results in pivotal clinical trials involving novel direct oral anticoagulants, vitamin K antagonists remain the most commonly prescribed anticoagulant. Newer oral anticoagulants are ...

DES, adding clopidogrel in the chronic phase of coronary disease had no ischemic benefit and increased bleeding.

To read this article for CME, click here. July 27, 2007 — Oral anticoagulants are superior to antiplatelet therapy for primary stroke prevention in patients with nonvalvular atrial fibrillation (AF), ...